Ototoxicity prevention during the SARS-CoV-2 (COVID-19) emergency

Aim of this paper is to remind the risk of ototoxicity when using chloroquine and hydroxychloroquine, in particular as prophylactic agents against SARS-CoV-2, during the pandemic. Healthy subjects taking chloroquine and hydroxychloroquine as prophylactic agents against SARS-CoV-2, during the pandemi...

Descripción completa

Detalles Bibliográficos
Autores principales: Ciorba, Andrea, Skarżyński, Piotr Henryk, Pelucchi, Stefano, Hatzopoulos, Stavros
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Ltd on behalf of International Society for Antimicrobial Chemotherapy. 2020
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7568171/
https://www.ncbi.nlm.nih.gov/pubmed/33075521
http://dx.doi.org/10.1016/j.jgar.2020.09.030
_version_ 1783596475589066752
author Ciorba, Andrea
Skarżyński, Piotr Henryk
Pelucchi, Stefano
Hatzopoulos, Stavros
author_facet Ciorba, Andrea
Skarżyński, Piotr Henryk
Pelucchi, Stefano
Hatzopoulos, Stavros
author_sort Ciorba, Andrea
collection PubMed
description Aim of this paper is to remind the risk of ototoxicity when using chloroquine and hydroxychloroquine, in particular as prophylactic agents against SARS-CoV-2, during the pandemic. Healthy subjects taking chloroquine and hydroxychloroquine as prophylactic agents against SARS-CoV-2, during the pandemic, should be screened periodically, at least by Otoacoustic Emissions (OAEs) in order to detect early manifestations of possible cochlear ototoxic damages.
format Online
Article
Text
id pubmed-7568171
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher The Author(s). Published by Elsevier Ltd on behalf of International Society for Antimicrobial Chemotherapy.
record_format MEDLINE/PubMed
spelling pubmed-75681712020-10-19 Ototoxicity prevention during the SARS-CoV-2 (COVID-19) emergency Ciorba, Andrea Skarżyński, Piotr Henryk Pelucchi, Stefano Hatzopoulos, Stavros J Glob Antimicrob Resist Short Communication Aim of this paper is to remind the risk of ototoxicity when using chloroquine and hydroxychloroquine, in particular as prophylactic agents against SARS-CoV-2, during the pandemic. Healthy subjects taking chloroquine and hydroxychloroquine as prophylactic agents against SARS-CoV-2, during the pandemic, should be screened periodically, at least by Otoacoustic Emissions (OAEs) in order to detect early manifestations of possible cochlear ototoxic damages. The Author(s). Published by Elsevier Ltd on behalf of International Society for Antimicrobial Chemotherapy. 2020-12 2020-10-17 /pmc/articles/PMC7568171/ /pubmed/33075521 http://dx.doi.org/10.1016/j.jgar.2020.09.030 Text en © 2020 The Author(s) Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Short Communication
Ciorba, Andrea
Skarżyński, Piotr Henryk
Pelucchi, Stefano
Hatzopoulos, Stavros
Ototoxicity prevention during the SARS-CoV-2 (COVID-19) emergency
title Ototoxicity prevention during the SARS-CoV-2 (COVID-19) emergency
title_full Ototoxicity prevention during the SARS-CoV-2 (COVID-19) emergency
title_fullStr Ototoxicity prevention during the SARS-CoV-2 (COVID-19) emergency
title_full_unstemmed Ototoxicity prevention during the SARS-CoV-2 (COVID-19) emergency
title_short Ototoxicity prevention during the SARS-CoV-2 (COVID-19) emergency
title_sort ototoxicity prevention during the sars-cov-2 (covid-19) emergency
topic Short Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7568171/
https://www.ncbi.nlm.nih.gov/pubmed/33075521
http://dx.doi.org/10.1016/j.jgar.2020.09.030
work_keys_str_mv AT ciorbaandrea ototoxicitypreventionduringthesarscov2covid19emergency
AT skarzynskipiotrhenryk ototoxicitypreventionduringthesarscov2covid19emergency
AT pelucchistefano ototoxicitypreventionduringthesarscov2covid19emergency
AT hatzopoulosstavros ototoxicitypreventionduringthesarscov2covid19emergency

Ejemplares similares